Posted inGenetics
As Pipeline Advances, Recursion Expands AI Focus to Clinical Trials
Najat Khan, PhD, Recursion Pharmaceuticals chief R&D officer and chief commercial officer With at least seven of its programs expected…
Posted inGenetics
Scratching an Itch: A Double-Edge Sword That Sharpens Inflammation and Immune Defenses
Researchers at the University of Pittsburgh have uncovered new insights into the dual nature of scratching an itch, indicating that…
Posted inGenetics
Rentschler Withdraws from Cell and Gene Therapy Arena
Rentschler Biopharma is withdrawing from the field of cell and gene therapy, ceasing operations at its Stevenage, UK site, and…
Posted inGenetics
Resolved Transthyretin Protein Structures Could Lead to New Therapies for Progressive Amyloidosis
Scientists from Scripps Research have uncovered new structures of transthyretin, a protein that moves important hormones like thyroxine through blood…
Posted inGenetics
A Call to Action: Building Vaccine Trust Through Transparency
After returning from the JPMorgan Healthcare Conference last week, I was pleased to hear that some of the pharmaceutical industry’s…
Posted inGenetics
Is Lifetime Cancer Risk Established before Birth?
The results of a study in mice by Van Andel Institute (VAI) scientists suggest that a person’s lifetime risk for…
Posted inGenetics
Epigenetic Chromosomal State Remains Stable in Plants after Inversion by CRISPR/Cas Technology
Chromosomal rearrangements, such as chromosome segment inversions, may affect the epigenetic landscape as well as gene expression. Different kinds of…
Posted inGenetics
After a Year of Launches, 10x Refocuses on Customer Support, Biopharma Market Growth
After launching numerous new products for its three platform technologies throughout 2024, 10x Genomics is taking a pause from rollouts,…
Posted inGenetics
Maximizing Process Optimization
The many stages of a bioprocess offer endless opportunities for optimization. Improving a process starts with process design (PD) and…
Posted inGenetics
Purification Option Eases the Bottlenecks in AAV Production
Adeno-associated viruses (AAVs) are used in nearly a dozen FDA-approved therapies and more than 900 R&D projects to deliver therapeutic…